DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
0.4500
+0.0217 (5.07%)
At close: Aug 13, 2025, 4:00 PM
0.4494
-0.0006 (-0.13%)
After-hours: Aug 13, 2025, 7:03 PM EDT

Chico's FAS Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
27.1527.0420.3527.6620.517.58
Revenue Growth (YoY)
41.79%32.86%-26.41%34.82%170.76%0.22%
Cost of Revenue
8.288.759.9813.6412.445.06
Gross Profit
18.8718.310.3714.018.072.51
Selling, General & Admin
37.9546.141.846.8262.3627.98
Research & Development
18.5624.1820.2519.6517.224.43
Operating Expenses
60.4475.3166.4370.8282.5432.42
Operating Income
-41.58-57.02-56.06-56.81-74.47-29.9
Interest Expense
---0.53-2.6--
Interest & Investment Income
0.911.121.870.510.040.06
Currency Exchange Gain (Loss)
-0.23-0-0.210.24-0.20.45
Other Non Operating Income (Expenses)
-2.3912.03-4.34-3.53-0.08-0.05
EBT Excluding Unusual Items
-43.29-43.87-59.27-62.19-74.71-29.45
Merger & Restructuring Charges
-0.73-0.73-0.13--2.02-
Gain (Loss) on Sale of Investments
--0.04---
Pretax Income
-44.02-44.6-59.36-62.19-76.73-29.45
Income Tax Expense
0.16-1.850.0600.03-
Net Income
-44.18-42.75-59.43-62.19-76.76-29.45
Preferred Dividends & Other Adjustments
-8.46-12.66-4.57-2.24-9.243.66
Net Income to Common
-35.72-30.09-54.86-59.96-67.52-33.1
Shares Outstanding (Basic)
54492824176
Shares Outstanding (Diluted)
54492824176
Shares Change (YoY)
63.26%72.84%20.04%42.45%178.23%163.15%
EPS (Basic)
-0.66-0.61-1.93-2.54-4.07-5.55
EPS (Diluted)
-0.66-0.61-1.93-2.54-4.07-5.55
Free Cash Flow
-26.92-38.7-30.96-48.29-50.67-17.85
Free Cash Flow Per Share
-0.49-0.79-1.09-2.04-3.05-2.99
Gross Margin
69.49%67.66%50.95%50.67%39.34%33.17%
Operating Margin
-153.15%-210.85%-275.46%-205.42%-363.06%-394.71%
Profit Margin
-131.56%-111.28%-269.56%-216.80%-329.16%-436.95%
Free Cash Flow Margin
-99.16%-143.12%-152.14%-174.60%-247.01%-235.67%
EBITDA
-35.26-49.59-51.08-52.09-70.02-29.71
EBITDA Margin
-129.87%-183.39%-250.96%-188.36%--
D&A For EBITDA
6.327.434.994.724.460.19
EBIT
-41.58-57.02-56.06-56.81-74.47-29.9
EBIT Margin
-153.15%-210.85%-275.46%-205.42%--
Revenue as Reported
27.1527.0420.3527.6620.51-
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q